Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | ANPEP | P15144 | 3/20 | 0.46 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.46 |
| ▸ | DNPEP | Q9ULA0 | 2/20 | 0.46 |
| ▸ | LARS1 | Q9P2J5 | 3/20 | 0.42 |
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ARG1 | P05089 | 1/20 | 0.36 |
| ▸ | ARG2 | P78540 | 1/20 | 0.36 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.35 |
| ▸ | CIT | O14578 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13789959 | 0.83 | SLC7A5 (0.54) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL8768451 | 0.81 | SLC7A5 (0.52) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL11078076 | 0.81 | SLC7A5 (0.52) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| Hydrochloric Acid SCHEMBL8624056 | 0.81 | SLC7A5 (0.52) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| Hydrochloric Acid SCHEMBL8624053 | 0.81 | SLC7A5 (0.52) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL11078078 | 0.81 | SLC7A5 (0.52) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL9113004 | 0.79 | DPP7 (0.52) | SLC7A5ANPEPRNPEPDNPEPLARS1 | |
| SCHEMBL3359437 | 0.78 | — | — | |
| SCHEMBL25326532 | 0.78 | — | — | |
| SCHEMBL1277891 | 0.78 | ANPEP (0.68) | SLC7A5ANPEPRNPEPDNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234912-A1 | NOVEL ANALOGS OF PTEROSTILBENE AMINO ACID BEARING CARBONATES FOR TREATING A NON-ALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS | APICAL MOLECULAR BIOTECH CO., LTD. (TW) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234912-A1 | NOVEL ANALOGS OF PTEROSTILBENE AMINO ACID BEARING CARBONATES FOR TREATING A NON-ALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS | FABP1, GLS2, SLC1A5 | SLC7A5 25/4885ANPEP 236/4885RNPEP 349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.